Century Therapeutics
IPSC
#8263
Rank
A$0.48 B
Marketcap
A$2.70
Share price
0.00%
Change (1 day)
259.84%
Change (1 year)

Operating Margin for Century Therapeutics (IPSC)

Operating Margin as of September 2026 (TTM): -8.83%

According to Century Therapeutics's latest financial reports and stock price the company's current Operating Margin is -8.83%. At the end of 2025 the company had an Operating Margin of -8.84%.

Operating Margin history for Century Therapeutics from 2022 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
2025-8.84%-99.53%
2024-1,893.70%-68.6%
2023-6,030.96%139.64%
2022-2,516.66%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.